UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000019740
Receipt No. R000022795
Scientific Title A multicenter randomized controlled trial on early fluid resuscitation in extensively burned patients.
Date of disclosure of the study information 2015/11/16
Last modified on 2021/05/15 (Ver. 17)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A multicenter randomized controlled trial on early fluid resuscitation in extensively burned patients.
Acronym Burn RCT on fluid resuscitation.

(FORECAST Burn)
Scientific Title A multicenter randomized controlled trial on early fluid resuscitation in extensively burned patients.
Scientific Title:Acronym Burn RCT on fluid resuscitation.

(FORECAST Burn)
Region
Japan

Condition
Condition Burn
Classification by specialty
Emergency medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim of this study was to verify the effectiveness to attenuate excessive fluid using a resuscitation fluid formula advocated by American Burn Association for Burn Injuries on early resuscitation in extensively burned patients.
Basic objectives2 Others
Basic objectives -Others The respiratory dysfunction within 1 week after burn
(PaO2/FiO2 ratio)
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes The respiratory dysfunction within 1 week after burn.
(PaO2/FiO2 ratio)
Key secondary outcomes 1. Renal dysfunction within 1 week after burn.
(serum creatinine and BUN)
2. Occurrence rate of abdominal compartment syndrome within 28 days after burn.
3. The 28-day and hospital mortality.
4. Fluid volume required within 48 hours after burn.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Open -no one is blinded
Control Dose comparison
Stratification YES
Dynamic allocation YES
Institution consideration Institution is considered as a block.
Blocking YES
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 Dose of Ringer lactate solution
(2mL*%TBSA*body weight divided by 2*8 hours is started/4mL*%TBSA*body weight
divided by 2*8 hours is started)
Interventions/Control_2 Initial resuscitation period
(2 days/2 days)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
21 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with burn surface area of 20-80%TBSA and age >21 years old.
Key exclusion criteria Cardiopulmonary arrest
Chemical burn
Electric burn
Case with time interval beyond 4 hours after burn
Case received fluid resuscitation before the arrival
Comorbidity; heart disease, COPD, chronic renal failure, hepatic cirrhosis.
Case combined trauma.
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Satoshi
Middle name
Last name GANDO
Organization Hokkaido University Graduate School of Medicine
Division name Acute and Critical Care Medicine
Zip code 060-8638
Address N15W7, Kita-ku, Sapporo
TEL +81-11-706-7377
Email gando@med.hokudai.ac.jp

Public contact
Name of contact person
1st name Shuta
Middle name
Last name Fukuda
Organization Japanese Association for Acute Medicine
Division name Office
Zip code 113-0033
Address 3-3-12, Hongo, Bunkyo-ku, Tokyo
TEL +81-3-5840-9870
Homepage URL https://c.umin.ac.jp/idc/index?proj_id=P00221&ctl=user
Email editorial-jaam@umin.net

Sponsor
Institute Japanese Association for Acute Medicine
Japanese Society for Burn Injuries
Institute
Department

Funding Source
Organization Japanese Association for Acute Medicine, Japan Society for the Promotion of the Science
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Hokkaido University Graduate School of Medicine
Address N15W7, Kita-ku, Sapporo
Tel +81-3-5840-9870
Email gando@med.hokudai.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 11 Month 16 Day

Related information
URL releasing protocol http://www.jaam.jp/html/jaamforecast/index.html
Publication of results Published

Result
URL related to results and publications https://www.sciencedirect.com/science/article/pii/S2468912221000092?via%3Dihub
Number of participants that the trial has enrolled 39
Results There were no statistically significant differences between the 2 groups in the serum creatinine, and acute kidney injury based on the KDIGO guideline within 48 h after arrival at the hospital, survival rate on the 28th day, and discharge survival rate. The Modified Brooke formula group failed to achieve the target urine output corresponding to the infusion volume within 8 h after arrival, especially in more than 40% TBSA burn patients, but it did not become a clinical problem.
Results date posted
2021 Year 05 Month 15 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
2021 Year 03 Month 26 Day
Baseline Characteristics The inclusion criteria were as follows. More than 21 years old, a burn area of 20%- 80% TBSA, and freely agreed to the contents of the document after giving their informed consent. The exclusion criteria were cardiopulmonary arrest before or on arrival, more than 4 h lapsed from injury to hospitalization, transfer cases with initial resuscitation already started, chemical burn, electric shock burn, history of heart disease (e.g. old myocardial infarction or valvular heart disease), history of chronic respiratory disease (e.g. chronic obstructive pulmonary disease and pulmonary fibrosis), history of renal disorders (e.g. chronic renal failure), liver cirrhosis of Child-Pugh classification C and complicated with trauma with an Abbreviated Injury Scale(AIS) more than 3.
Participant flow The study design was an exploratory, randomized, open-label, and controlled trial. This randomization was performed by the Pocock method based on the factors of burn surface area, inhalation injury, age, and gender at each facility. The registration of cases and randomization into two groups were performed by participating in registration facilities on the UMIN's website. One group was the conventional group treated using lactated Ringer's solution based on the Baxter formula, and the other was the intervention group treated using the fluid resuscitation method shown in the Modified Brooke formula.
Adverse events Nothing
Outcome measures The primary endpoint was a respiratory disorder P/F (PaO2/FiO2) ratio within 1 week after burn injury. The arterial blood sample was collected from an arterial line at the designated time point according to the time of arrival at the hospital, and data were acquired. Therefore, the data obtained by arterial blood sampling at that time show the result of a single data point and not the results of data acquired multiple times. Secondary endpoints were renal disorder (serum creatinine and blood urea nitrogen) within 48 h, the occurrence rate of abdominal compartment syndrome (ACS) within 28 days, survival rate on the 28th day, and volume of fluid resuscitation required for 2 days after hospitalization. We also examined each endpoint, including the urine output per body weight and hour, in the major burn patients with 20%-80% TBSA and with 40%-80% TBSA.
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 11 Month 16 Day
Date of IRB
2015 Year 08 Month 10 Day
Anticipated trial start date
2016 Year 01 Month 01 Day
Last follow-up date
2019 Year 12 Month 31 Day
Date of closure to data entry
2019 Year 12 Month 31 Day
Date trial data considered complete
2019 Year 12 Month 31 Day
Date analysis concluded
2021 Year 03 Month 26 Day

Other
Other related information

Management information
Registered date
2015 Year 11 Month 10 Day
Last modified on
2021 Year 05 Month 15 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022795